Toll Group, a subsidiary of Japan Post Holdings, has opened a new 5,800-square-metre healthcare warehouse and distribution centre at Hazelmere in Perth, Western Australia. The facility commenced operations in September 2025 and represents the company’s fifth dedicated healthcare site in Australia, reinforcing its position as a major player in pharmaceutical and medical logistics across the Asia Pacific region.
Facility Details
The Hazelmere facility is purpose-built to handle the demanding requirements of healthcare supply chain operations. Spanning 5,800 sqm, the site incorporates both ambient and temperature-controlled storage zones, allowing Toll to service a broad spectrum of healthcare products from general medical supplies through to highly sensitive biologics.
The warehouse has been designed to meet the stringent compliance and quality standards required by Australia’s Therapeutic Goods Administration (TGA), ensuring that pharmaceutical products, medical devices, and other healthcare goods are stored and distributed under tightly controlled conditions.
With this opening, Toll now operates five healthcare-specific facilities across Australia, providing national coverage for its growing portfolio of healthcare and life sciences customers in Western Australia and beyond.
Healthcare Investment Program
The Perth facility forms part of Toll’s A$100 million investment in healthcare services across Asia Pacific, a programme designed to grow the company’s supply chain capabilities and assets while providing scalability for customers operating in the sector.
Key projects within this investment programme include:
- Melbourne, Victoria: A state-of-the-art distribution centre built for CSL Seqirus, supporting the manufacture and distribution of influenza vaccines
- Richlands, Queensland: A new facility dedicated to vaccine distribution, strengthening cold chain coverage across northern Australia
- Hazelmere, Perth: The newly opened Western Australian healthcare hub
The investment is also generating hundreds of new jobs nationally. Approximately 130 healthcare-specific roles have been added to Toll’s existing Australian workforce of more than 6,000 employees, with further growth anticipated as the programme continues to scale.
Cold Chain Capabilities
One of the most significant aspects of the Hazelmere facility is its advanced cold chain infrastructure. The site features ambient storage alongside dedicated cool-room facilities and ultra-low temperature freezers, enabling the safe handling and storage of specialised vaccines that require strict temperature control throughout the supply chain.
This capability is increasingly important as the healthcare logistics sector adapts to growing demand for temperature-sensitive biologics, mRNA-based therapies, and next-generation vaccines. Toll’s investment in ultra-low freezer capacity positions the company to support both routine immunisation programmes and emergency pandemic response efforts from the Western Australian market.
Strategic Significance
The expansion into Perth addresses a longstanding gap in healthcare logistics coverage for Western Australia. Previously, many pharmaceutical supply chains relied on east coast distribution hubs, resulting in longer lead times for healthcare providers in the west.
By establishing a dedicated facility in Hazelmere, Toll can offer faster turnaround for hospitals, pharmacies, and aged care providers across Western Australia, while also providing a strategic buffer for national supply chain resilience.
For third-party logistics providers and warehouse operators servicing the healthcare sector, Toll’s continued investment signals a broader trend: the healthcare supply chain is becoming more specialised, more regulated, and more dependent on purpose-built infrastructure that can guarantee product integrity from receipt through to final delivery.